Aktis Oncology, Inc. Common stock (AKTS)

$15.73 -$0.99 (-5.91%) 4:40 AM 10/24/2026
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $837.63M

  • Day's Range

    $15.65 - $16.61

  • Volume

    375,223

  • 52 Week Low / High

    $14.72 - $34.19

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

AKTS's Dividend
-
Amount
-
Dividend Yield
Dec 2
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %

Analyst ratings: Buy 10, Hold 0, Sell 0.

Company News

No news articles available.

Similar Stocks

  • CGEM.US Logo

    CGEM

    Cullinan Oncology Llc

  • GLUE.US Logo

    GLUE

    Monte Rosa Therapeutics Inc

  • JBIO.US Logo

    JBIO

    Jade Biosciences, Inc.

  • MLTX.US Logo

    MLTX

    Moonlake Immunotherapeutics

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free